Logga in

Gradinger, R.

Chirurgisches Forum und DGAV Forum 2010

Gradinger, R. - Chirurgisches Forum und DGAV Forum 2010, e-bok


E-bok, PDF, Adobe DRM-skydd
ISBN: 9783642121920

Skriva utInte tillåtet
Kopiera till urklippInte tillåtet

Table of contents

I. Fritz-Linder-Preisträsgersitzung

1. Differential Transfection on Cell Chips for High Throughput Analysis of Paracrine Gene Activities in Angiogenesis and Tumor Invasion
E. Kuhn, A. Konrad, E. Naschberger, R.S. Croner, H. Münstedt, M. Stürzl

2. Liver cell proliferating in vitro repopulate hepatocytes and bile-duct like cells following transplantation
S. König, P. Krause, H. Becker, I. Probst

3. Analysis of energy expenditure after Roux-en-Y Gastric Bypass in rats
M. Bueter, F. Seyfried, A. Thalheimer, C. Loewenstein, C.W. le Roux, S.R. Bloom, T.A. Lutz, C.T. Germer

4. Bursting pressure, expression of MMP 13 and VEGF of sutured and glued colorectal anastomoses in the rat model
U. Pohlen, H. Rieger, H.J. Buhr

5. New osteosynthesis techniques: The dynamic locking screw (DLS)
S. Döbele, C. Horn, S. Eichhorn, A. Buchholtz, M. Lucke, R. Koch, U. Stöckle

II. Onkologie: Genexpression

6. Gene expression analysis in different malignant tumor cell lines following apoptosis induction by Taurolidine using cDNA-Microarray technique
A.M. Chromik, A. Daigeler, D. Bulut, A. Flier, C. May, K. Harati, D. Sülberg, U. Mittelkötter, S. Hahn, W. Uhl

7. Genetic profiling of brain- and bone-seeking clones of MDA-MB-231 breast cancer cells
A.M. Stark, R. Mentlein, H.M. Mehdorn, J. Held-Feindt

8. High expression of enteric α-defensin (HD-6) in colorectal adenomas and carcinomas
H. Mothes, M. Radeva, F. Jahns, U. Settmacher

9. HERG1 gene expression as a specific tumor marker in colorectal tissue
J.H. Dolderer, H. Schuldes, H. Bockhorn, M. Altmannsberger, C. Lambers, D. Zabern, D. Jonas, H. Schwegler, R. Linke, U.H. Schröder

10. Micro-RNAs improve the staging in patients with locally advanced esophageal cancer
R. Hummel, D.J. Hussey, M.Z. Michael, M. Brüwer, J. Haier, D. Palmes, D.I. Watson

11. Neoadjuvant radiochemotherapy in adenocarcinoma of the esophagus: Impact of ERCC1 gene polymorphisms for prediction of response and prognosis
R. Metzger, U. Warnecke-Eberz, F. Kütting, H. Alakus, U. Drebber, J. Brabender, D. Vallböhmer, S. Mönig, A.H. Hölscher, E. Bollschweiler

III. Onkologie: Ösophaguskarzinom

12. Successful evaluation of a new animal model using mice for esophageal adenocarcinoma
M.C. Raggi, R. Langer, M. Feith, H. Friess, J. Theisen

13. The Stem Cell Marker LgR5 is Expressed in a Subpopulation of (Ki-67+) Cells in Barrett’s Esophagus and Barrett’s-Associated Adenocarcinomas
H. Burkhard, A. Rahden, L. Stürmer, C. Reiber, M. Lazariotou, S. Kircher, S. Gattenlöhner, C.-T. Germer, M. Grimm

14. The relevance of the therapeutic target structure EpCAM (CD326) for the progression of esophageal carcinoma
C. Driemel, P. Panagiotidou, I. Hoffmann, S. Schumacher, A. Luca, J. Pietsch, W.T. Knoefel, N.H. Stoecklein

15. Inhibition of YB-1 as a novel approach to decrease the expression of EGFR, HER-2 and IGF-1R in esophageal cancer
S. Thieltges, T. Kalinina, T.Y. Vashist, R. Simon, J. Izbicki, E. Yekebas

16. Leukocyte-depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer
F.C. Ling, A.H. Hölscher, D. Vallböhmer, D. Schmidt, S. Picker, B.S. Gathof, E. Bollschweiler, P.M. Schneider

IV. Onkologie: Magen- und Pankreaskarzinom

17. Induction of metastases and peritoneal carcinomatosis in gastric cancer by overexpression of PGK1
I. Königsrainer, S. Beckert, J. Glatzle, M. Löffler, H. Northoff, B.L.D. M. Brücher, A. Königsrainer, D. Zieker

18. EGF-receptor targeting is not effective in experimental gastric cancer due to an inactive receptor
B. Hotz, U. Keilholz, H.J. Buhr, H.G. Hotz

Active-specific tumor cell vaccination after lymphopenia-induced lymphocyte proliferation followed by T cell reconstitution (LRAST) induces therapeutic T cells in a murine gastric cancer model
N.K. Engel, M. Rusan, I. Assmann, D. Rüttinger, N. Schupp, G. Meimarakis, W. Zimmermann, R.A. Hatz, H. Winter

20. Influence of SFRP1 on pancreatic cells
D. Wehrum, A. Hartmann, R. Stoehr, R. Gruetzmann, C. Pilarsky, H.D. Saeger

21. Midkine is frequently overexpressed and promotes pancreatic cancer cell proliferation
C. Güngör, M. Frank, L. Dietrich, E. Yekebas, M. Bockhorn, J.R. Izbicki

22. Sox9-associated overexpression of IFIT3 leads to pancreatic cancer progression by activation of »pseudoinflammatory« pathways
P. Camaj, I. Ischenko, H. Seeliger, A. Renner, S. Krebs, G.J. Arnold, M.K. Angele, K.W. Jauch, C.J. Bruns

23. Epithelial to mesenchymal transition in the metastatic process of pancreatic ductal adenocarcinoma
W.A. Mardin, C. Haane, S. Irmscher, C. Schleicher, N. Senninger, J. Haier, S.T. Mees

V. Onkologie: Pankreaskarzinom

24. Expression of GLUT-2 in PanINs of murine and human pancreatic carcinoma
R. Schneider, D.K. Bartsch, V. Fendrich

25. A novel approach for specific tumor targeting of pancreatic carcinoma with Shiga toxin B
M. Maak, R. Rosenberg, B. Holzmann, J. Kleeff, L. Johannes, H. Friess, K.-P. Janssen

26. HSP90 is a promising target in Gemcitabine and 5-FU resistant pancreatic cancer
J.L. Rabofski, Y.K. Vashist, T. Kalinina, C. Guengor, J.R. Izbicki, E.F. Yekebas

27. STAT5b as novel target for anti-neoplastic therapy in human pancreatic cancer
S.A. Lang, C. Moser, C. Hackl, H. Schenk, H.J. Schlitt, O. Stöltzing, E.K. Geissler

28. The Angiotensin-I-converting Enzyme Inhibitor Enalapril and Aspirin delay progression of Pancreatic Intraepithelial Neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer
V. Fendrich, N.M. Chen, M. Neef, J. Waldmann, M. Buchholz, E.P. Slater

29. Chronic stress profoundly impairs survival in pancreatic cancer but prognosis can be significantly improved by beta blockers
L.I. Partecke, A. Käding, S. Speerforck, M. Sendler, S. Diedrich, F.U. Weiss, C.D. Heidecke, W. Bernstorff

VI. Onkologie: Kolorektales Karzinom

30. Epithelial-Mesenchymal-Transition (EMT): The role of E-Cadherin transcription regulators Snail, Twist1 and Twist2 in colorectal adenomas and carcinomas
G. Flügen, N.H. Stoecklein, S. E. Baldus, T.A. Topp, M. Schmelzle, W. T. Knoefel, F. Aydin

31. Identification of potential colorectal oncogenes on chromosome 13q
G. Emons, M. Grade, J. Camps, A.B. Hummon, J. Gaedcke, H. Becker, N. Caplen, T. Beissbarth, T. Ried, B.M. Ghadimi

32. Analysis of Lgr5, CD133, and ABCB5 in blood samples of patients with colorectal carcinoma (CRC) as an indicator of disseminated circulating tumour stem cells
M. Kim, C.-T. Germer, A.M. Waaga-Gasser, M. Gasser

33. Predictive biomarkers to select chemotherapeutic and molecular therapies in colorectal cancers and liver metastases
T. Singer, A. Bogner, K.-W. Jauch, B. Mayer

34. Establishment of a 3D-cell culture model to investigate therapeutic target structures in colorectal carcinomas
A.C. Luca, J.M. Pietsch, C. Driemel, S. Schumacher, C. Vay, W.T. Knoefel, N.H. Stoecklein

35. Cryoconservation and Xenotransplantation of colorectal carcinoma
M. Linnebacher, C. Maletzki, C. Ostwald, U. Klier, M. Krohn, E. Klar, F. Prall

VII. Onkologie: Prognose

36. Increased HER2 copy number in single disseminated tumor cells predicts survival of esophageal cancer patients
N.H. Stoecklein, M. Maneck, M. Meyer, S. Schumacher, G. Brockhoff, D. Will, W.T. Knoefel, C.A. Klein

37. Impact of the Glasgow Prognostic Score on perioperative Outcome and Survival in Esophageal Cancer
A. Kutup, Y.K. Vashist, J. Loos, J. Dedow, J. Metze, F. Gebauer, E. F. Yekebas, J.R. Izbicki

38. Heme oxygenase-1 GTn promotor polymorphism is a prognosticator of tumor recurrence and survival in pancreatic cancer
G. Uzunoglu, Y.K. Vashist, F. Gebauer, A. König, L. Deutsch, O. Zehler, V. Kalinin, J.L. Rabofski, A. Kutup, J.R. Izbicki, E.F. Yekebas

39. A signature of 112 genes identifies colorectal cancer patients with favorable prognosis
J. Gröne, H.J. Buhr, E. Staub

40. Neural invasion is a crucial prognostic factor in rectal cancer independent of neoadjuvant radiochemotherapy
F. Liebl, G.O. Ceyhan, K. Becker, M. Maak, H. Friess, R. Rosenberg

VIII. Onkologie: Therapie

41. Generation of highly pure fusions of tumor and antigen presenting cells
U. Klier, E. Klar, M. Linnebacher

42. Designer Host Defense Peptide as a new therapeutic option against soft tissue sarcoma?
C. Schubert, J. Hauk, F. Jacobsen, A. Daigeler, S. Langer, T. Hirsch, I. Stricker, Y. Shai, H.U. Steinau, L. Steinstraesser

43. RNAi-mediated inhibition of TCF7L2 sensitizes colorectal cancer cell lines to radiation
E. Kendziorra, M. Spitzner, G. Emons, K. Ahlborn, J. Gaedcke, M. Rave-Fränk, H. Becker, T. Beißbarth, B.M. Ghadimi, T. Ried, M. Grade

44. Dynamic Contrast-Enhanced MRI Monitoring proofs Inhibition of Tumor Growth and Angiogenesis by Sorafenib in an Experimental Tumor Model in Rats with immunohistological correlations
E.B. Schwarz, C.C. Cyran, P. Paprottka, S. Sourbron, J. Einem, R. Hinkel, O. Dietrich, B.J. Wintersperger, K. Nikolaou, M.F. Reiser, C.J. Bruns

45. Bipolar radiofrequency ablation for nodular thyroid disease – Ex vivo and in vivo evaluation of a dose-response relationship
C. Holmer, K.S. Lehmann, C. Seifarth, U. Zurbuchen, H.J. Buhr, J.P. Ritz

46. Therapy planning system for the calculation of the thermal destruction volume of radiofrequency ablation of liver tumors – ex-situ evaluation including the cooling effect of liver vessels
K.S. Lehmann, B.B. Frericks, T. Kröger, V. Knappe, A. Weihusen, C. Holmer, A. Schenk, U. Zurbuchen, H.O. Peitgen, H.J. Buhr, J.P. Ritz

IX. Molekulare Biologie

47. Mismatch-repair Genes as a model for the LOVD (Leiden Open Variation Database) – The way to move forward in unclassified variants
G. Möslein, F. Macrae, J. den Dunnen

48. Deregulation of HIF1-alpha and hypoxia regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue – influence of a modulated host-stroma on the prognosis of HCC
F. Simon, M. Bockhorn, C. Praha, H.A. Baba, C.E. Broelsch, A. Frilling, F. Weber

49. RIP2beta: Identification and characterization of a novel alternative splice variant of the receptor interacting protein kinase RIP2
A. Krieg, G. Le Negrate, W.T. Knoefel, J.C. Reed

50. Multimerization of adiponectin is influenced by site-specific phosphorylation
A. Hillenbrand, J. Hofmann, R. Alberts, M. Wabitsch, P. Fischer-Posovszky, O. Prokopchuk, A.M. Wolf, D. Henne-Bruns, U. Knippschild

51. Macrophages possess a variable immunoreceptor that is implicated in atherosclerosis
K. Puellmann, T. Fuchs, J. Kzhyshkowska, A. Gratchev, A. Emmert, J. Fleig, S. Oniga, R. Laird, J.T. Wessels, N.M. Heida, K. Schäfer, H. Becker, A. Ganser, M. Neumaier, W.E. Kaminski, A.W. Beham

X. Stammzellen

52. Improved differentiation of hepatozyte-like cells from adipose tissue
via epigenetic changes: possible application for cell therapies in surgery
C. Seeliger, M. Römer, S. Ehnert, S. Gillen, H. Friess, U. Stöckle, A.K. Nüssler

53. Adipose-derived Mesenchymal Stem Cells have a great Potential for Osteogenic Differentiation
I. Kerler, S. Ehnert, A. Schmitt, C. Seeliger, M. Lucke, U. Stöckle, A.K. Nüssler

54. Revascularization and osteocytic repopulisation of avital cortical bone with vascularised scaffold seeded with osteogenic induced adipose-derived stem cells (O-ADSC) in a rabbit model
O. Kloeters, I. Berger, K. Megerle, H. Ryssel, M. Pelzer, G. Germann

55. The effect of chronic and acute wound fluids on human keratinocytes and adipose-derived stem cells
T.A. Spanholtz, O.C. Thamm, V. Phan, M. Maegele, A. Schneider, N. Bader, E. Neugebauer

56. Hepatic Growth Factor (HGF)-concentrations in patients serum subsequent to partial hepatectomy are positively correlated with extend of parenchymal loss and post operative peripherally mobilised CD34+ and CD133+ stem cells
J. Schulte am Esch, M. Ralemska, M. Schmelzle, A. Krieg, R. Tustas, C. Duhme, A. Alexander, G. Fürst, M. Klein, I. Bruns, R. Haas, C.F. Eisenberger, S. Topp, W.T. Knoefel

57. Depending on concurrent immunosuppression Mesenchymal Stem Cells differentially Influence heart graft survival
F.C. Popp, E. Eggenhofer, P. Renner, J. Steinmann, P. Piso, H.J. Schlitt, M.H. Dahlke

XI. Transplantation: Immunologie

58. Activation status of NK cells dictates T cell responses
A. Krömer, X. Xiao, G. Demirci, H.J. Schlitt, E.K. Geissler, X.C. Li

59. Pre-operative anti-donor T-cell reactivity as parameter to determine the risk of graft rejection following kidney transplantation
F. W. R. Vondran, K. Timrott, J. Tross, S. Kollrich, F. Lehner, J. Klempnauer, T. Becker, R. Schwinzer

60. Does leukocytic Acetylcholine contribute to chronic rejection of renal grafts?
J. Wilczynska, A. Zakrzewicz, S. Wilker, I. Wessler, W. Padberg, W. Kummer, V. Grau

61. Inhibition of >>Triggering receptor expressed on myeloid cells 1<< (Trem-1) prolongs allograft survival during chronic cardiac rejection
G. Schiechl, H.J. Schlitt, E.K. Geissler, S. Fichtner-Feigl

62. Influence of Donor Age on the Immune Response after Transplantation
C. Denecke, X. Ge, I. Kim, D. Bedi, A. Jurisch, J. Pratschke, P. Neuhaus, S.G. Tullius

XII. Transplantation: Leber und Pankreasinseln

63. Hemoglobin-Glutamer 200 (Oxyglobin®) Preconditioning Of The Liver Reduces Cold Ischemia/Reperfusion Injury
S.A. Topp, A. Macher, A. Krieg, S.E. Baldus, M. Vaassen, T. Hohlfeld, N.H. Stoecklein, C.F. Eisenberger, W.T. Knoefel

64. Graft preconditioning with low-dose tacrolimus (FK506) and nitric oxide inhibitor (AGH) reduces ischemia/reperfusion injury after liver transplantation in the rat
E. Matevossian, D. Doll, J. Altomonte, M. Werner, M. Kriner, A. Preissel, S. Thorban, V. Aßfalg, A. Novotny, C. Riediger, N. Hüser

65. MDDP: a new method to protect marginal liver graft against ischemia/reperfusion injury
K. Seibert, M. Heesen, O. Kollmar, M.K. Schilling, M.D. Menger, M.R. Moussavian

66. Assessment of a chloride-poor vs. a chloride-containing modified HTK solution in a rat liver transplantation model
C.D. Fingas, S. Wu, Y. Gu, J. Wohlschlaeger, U. Dahmen, A. Paul, H. Groot, U. Rauen

67. Post-hoc reconditioning of cold stored livers by short term oxygen persufflation
M. Kötting, T. Minor

68. Genexpression analysis in proliferating islets of Langerhans
Stephan Kersting, H. Steinbach, J. Roth, J. Sailer, R. Grützmann, H.D. Saeger, C. Pilarsky

69. Beta cell renewal within transplanted mouse islets
Christian Krautz, S. Wolk, A. Steffen, K.-P. Knoch, H.-D. Saeger, M. Solimena, S. Kersting

XIII. Ischämie/Reperfusion und Transplantation

70. Controlled reperfusion with cold Buckberg solution improves donor lung function in case of Non-Heart- Beating donor (NHBD) – examination of isolated perfused pig lung lobes
Andreas Kirschbaum, E. Palade, G. Pache, J. Guttmann, B. Passlick

71. ATIII and NAC reduce microvascular thrombus formation in postischemic tissue in vivo

Anja Püschel, N. Lindenblatt, J. Katzfuß, B. Vollmar, E. Klar

72. Renoprotective effects of progenitor cell therapy in renal ischemia-reperfusion injury: decompression required
T. Herrler, A. Tischer, A. Meyer, S. Nowak, J. Andrassy, M. Guba, P. Bartenstein, K.-W. Jauch, M. Hacker

73. Graft treatment with Bilirubin ameliorates cardiac ischemia reperfusion injury
Florian Bösch, M. Thomas, P. Kogler, A. Kostron, S.-L. Son, A. Kaiser, D. Wiedemann, J. Troppmair, R. Margreiter, R. Öllinger

XIV. Leberschaden und Leberregeneration

74. The atrophie/hypertrophie response after portal branch ligation influences cellular and microvascular remodeling, hyperoxygenation and cell proliferation within the ligated liver due to time-dependent growth-factor expression
O. Kollmar, M. Corsten, C. Scheuer, M.K. Schilling, M.D. Menger

75. Mutation of mitochondrial ATP8 gene improves hepatic energy status in a murine model of acute endotoxemic liver failure
A. Hildebrandt, B. Scholz, T. Minor, S.M. Ibrahim, B. Vollmar, C. Eipel

76. P-selectin glycoprotein ligand-1 leukocyte recruitment regulates hepatocellular damage in obstructive cholestasis
S. Dold, M.W. Laschke, S. Richter, M.K. Schilling, M.D. Menger, H. Thorlacius

77. Darbepoetin-alpha inhibits the perpetuation of necro-inflammation and attenuates cholestatic fibrosis in mice
M. Sigal, N. Siebert, K. Abshagen, B. Vollmar, C. Eipel

78. Elevated expression of ALR in human NASH tissue specimens
M. Ilowski, S. Liebhaber, S. Gashi, J. Leise, C. Stielow, K.W. Jauch, M. Rentsch, W.E. Thasler

79. The liver-specific growth factor Augmenter of liver regeneration (ALR) has an anti-inflammatory impact on human hepatocytes via STAT3/SOCS3 inhibition
M. Parvanov, M. Ilowski, J. Leise, B. Donabauer, T.S. Weiss, K.W. Jauch, W.E. Thasler

XV. Sepsis und Ileus

80. Circulating receptors of the complement anaphylatoxin C5a – a new marker for sepsis?
D. Rittirsch, M.A. Flierl, G.A. Wanner, C.M.L. Werner, H.P. Simmen, P.A. Ward, M. Huber-Lang

81. Heme oxygenase (HO)-1 protects from septic liver injury by inhibition of hepatic leukocyte accumulation and improvement of microvascular perfusion
J. Roller, M.W. Laschke, C. Scheuer, M.D. Menger

82. Hemin Induction of HO-1 protects against LPS-induced Ileus
S. Bortscher, J. Chang, S. Schulz, A. Hirner, A. Bauer, M. Overhaus

83. The gastrointestinal field effect – a surgically initiated immunological interaction?
A. Koscielny, D. Engel, J. Maurer, A. Hirner, C. Kurts, J.C. Kalff

84. Role of the vagus nerve in the initial phase of the postoperative ileus
M.H. Müller, J. Glatzle, Z. Gao, M. Karpitschka, M.S. Kasparek, M.E. Kreis

85. Preoperative parenteral supplementation of long chain polyunsaturated fatty acids ameliorates postoperative ileus
S. Wehner, K.S. Meder, M. Lysson, A. Hirner, J.C. Kalff

86. Oral CPSI 2364 prevents postoperative ileus in swine without impairment of intestinal wound repair
T.O. Vilz, N. Sommer, S. Wehner, D. Pantelis, A. Hirner, J.C. Kalff

XVI. Pathophysiologie: Darm

87. Analysis of fat preference after Roux-en-Y Gastric Bypass in rats
F. Seyfried, A. Thalheimer, H. Ashrafian, S.R. Bloom, C.W. le Roux, T.A. Lutz, C.T. Germer, M. Bueter

88. GSK-3-beta inhibition ameliorates the course of experimental DSS-colitis in vivo

M.G. Laukötter, P. Nava, S. Koch, W. Lee, M. Bruewer, B.A. Babbin, C.A. Parkos, A. Nusrat

89. NALP expression in Paneth cells provides a novel track in IBD signaling
N. Slavova, A. Drescher, A. Visekruna, S. Dullat, A.-J. Kroesen, J.-P. Ritz, H.-J. Buhr

XVII. Plastische Chirurgie

90. Non-viral gene therapy for regeneration in an ischemic flap model
A. Slobodianski, C. Hartog, A. Kathöfer, J. Frenz, Z. Zhang, L. Evers, P. Mailänder, H.G. Machens

91. Characterization of Casein Kinase 1 delta and epsilon specific functions in neuronal regeneration processes
J. Bischof, A. Müller, M. Fänder, T.G. Hauk, U. Knippschild, D. Fischer

92. Peripheral nerve regeneration with microstructured collagen based nerve guides enriched with transdifferentiated adult mesenchymal stromal cells
A. Bozkurt, G.A. Brook, J. Scheffel, A. Böcker, K. Montzka, D. O’Dey, S. Möllers, R. Deumens, F. Schügner, I. Heschel, M. Wöltje, R. Tolba, T. Schwendt, C. Janzen, J. Weis, N. Pallua

93. The effect of recombinant growth and differentiation factor 5 (rhGDF-5) on the regeneration after peripheral nerve injury in rats
C. Sachs, N. Ofer, M. Sedigh Salakdeh, H. Müller, M. Reichenberger, G. Germann

XVIII. Tissue Engineering und Wundheilung

94. Laser-printing of skin cells and human mesenchymal stem cells for the production of cellular matrix constructs
H. Sorg, S. Kuhn, R. Gäbel, K. Reimers, L. Koch, M. Grüne, S. Schlie, N. Ma, B. Chichkov, G. Steinhoff, P.M. Vogt

95. Effect of blue light on human skin cells
C.M. Volkmar, A. Deck, C. Opländer, N. Pallua, C.V. Suschek

96. Accumulation of lactate in wound healing induces genes involved in mesenchymal stem cell homing
D. Zieker, M. Löffler, I. Königsrainer, S. Löb, J. Glatzle, A. Königsrainer, T.K. Hunt, H. Northoff, S. Beckert

97. Efficacy testing of topical delivered Moxifloxacin against MRSA in a porcine wound infection model
C. Fisahn, F. Jacobsen, T. Hirsch, I. Thiele, S. AL-Benna, B. Fugmann, H.U. Steinau, L. Steinstraesser

XIX. Biomaterialien

98. Culturing different cell lines on spider silk matrices as skin equivalent
A. Hillmer, H. Wendt, C. Allmeling, K. Reimers, J. Kuhbier, C. Kasper, P.M. Vogt

99. Implant improvement by nitinol-nanocoatings
S. Strauß, A. Hahn, S. Barcikowski, K. Reimers, P.M. Vogt

100. Investigation of the osteoclast-biomaterial interaction using Focused Ion Beam
Tim Habijan, T. Simon, T. Glogowski, G. Muhr, M. Köller

101. Impact of gentamicin supplemented polyvinylidenfluoride mesh materials on MMP-2 expression and tissue integration in a transgenic mice model
Marcel Binnebösel, C. Ricken, C.D. Klink, K. Junge, M. Jansen, V. Schumpelick, P.L. Jansen

102. The combination of vein and resorbable stent is an innovative procedure for the reconstruction of proximal ureter defect lesions
H.H. Wolters, S. Stöppler, L. Kebschull, H.P. Heistermann, H.U. Spiegel, D. Palmes

Nyckelord: Medicine & Public Health, Surgery, Surgical Oncology, Abdominal Surgery, Transplant Surgery

Deutsche Gesellschaft für Chirurgie
396 sidor
Hälsa, skönhet, mode

Liknande e-böcker